trending Market Intelligence /marketintelligence/en/news-insights/trending/FyTu224vTjY7GgnsGjXBLg2 content esgSubNav
In This List

Fresenius warned over plant violations; US FDA to review Sun Pharma's Seciera

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Video

S&P Capital IQ Pro | Powering Your Edge

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Fresenius warned over plant violations; US FDA to review Sun Pharma's Seciera

Top news

* The U.S. Food and Drug Administration warned Fresenius SE & Co. KGaA on violations of drug manufacturing regulations at its manufacturing plant in West Bengal, India. The warning came after the facility aborted 248 drug quality tests.

* Sun Pharmaceutical Industries Ltd. said the U.S. FDA accepted its new drug application for Seciera, a treatment for dry eye disease. Once approved, Sun Pharma plans to commercialize Seciera in the U.S. through its unit Sun Ophthalmics Inc.

Drug and product pipeline

* The China Food and Drug Administration granted priority review and approval status to Eisai Co. Ltd.'s Lenvima for treating hepatocellular carcinoma, a type of liver cancer. The treatment is approved for refractory thyroid cancer in over 50 countries.

Operational activity

* The U.K. is setting up the Future Vaccine Manufacturing Hub, a £10 million vaccine research network that aims to help poor countries improve vaccine manufacturing, the Financial Times reports.

* Shire plc filed its first submission for the company's new plasma manufacturing facility in Covington, Ga., with the U.S. FDA. The facility is expected to add approximately 30% capacity to the company's internal network once fully operational. Commercial production is expected to begin in 2018.

Other features

* Spinal cord implants are emerging as replacements for opioids for people suffering from debilitating nerve pain, Bloomberg Technology reports.

The day ahead

Early morning futures indicators pointed to a higher opening for the U.S. market.

In Asia, the Hang Seng was up 0.07% to 29,597.66. The Nikkei 225 rose 0.08% to 22,911.21.

In Europe as of midday, the FTSE 100 was up 0.14% to 7,603.56, while the Euronext 100 was down 0.13% to 1,039.67.

The Daily Dose is updated as of 6:30 a.m. ET. Some external links may require a subscription.